Cariprazine and Telotristat Ethyl: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 16, 2026 · Source data updated Jul 16, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Telotristat Ethyl
Cariprazine
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
You've been prescribed Xermelo (telotristat) and Vraylar (cariprazine) together. Here's the situation in plain terms. Telotristat can speed up an enzyme in your body called CYP3A4, and that same enzyme both creates and clears the active forms of cariprazine. Because of this, telotristat could change how much active cariprazine is around, but honestly, this exact combination hasn't been studied, so the true effect isn't known.
The good news is that this is a caution based on theory, not on reports of harm. Don't stop or change either medicine on your own. Just check in with your pharmacist or doctor so they can decide the safest plan and keep an eye on how you're doing.
Interaction: Telotristat ethyl is a CYP3A4 inducer; cariprazine is a CYP3A4 substrate whose active metabolites (desmethyl- and didesmethyl-cariprazine) are both formed and eliminated via CYP3A4.
- Direction/magnitude: Net effect on total active moiety exposure is unclear and unquantified because induction affects both formation and clearance of active metabolites. Not formally studied.
- Evidence: Theoretical; severity rated major.
- Onset: Unspecified (enzyme induction is typically delayed, days to weeks).
- Management: Coadministration is not recommended per labeling. If unavoidable, monitor closely for altered efficacy or emergent adverse effects and individualize therapy.
What happens
Effects on the cariprazine exposure has not been evaluated and the net effect is unclear
Interaction Deep Dive
It is advised against giving cariprazine (which is metabolized by CYP3A4) together with a CYP3A4 inducer. The generation as well as the clearance of cariprazine's active metabolites depend on CYP3A4. How CYP3A4 inducers alter cariprazine exposure has not been studied, so the overall consequence remains uncertain1.
Why it happens (mechanism)
Induction of CYP3A4-mediated metabolism of cariprazine
How to manage this interaction
Here is how a care team typically handles this pairing:
- The manufacturer labeling says this combination is not recommended, so your prescriber may consider an alternative or weigh whether both drugs are truly needed together.
- If you do take both, your team may monitor you more closely for changes in how well cariprazine is working or for new side effects, since the net effect is unpredictable.
- Your cariprazine dose may need to be adjusted and individualized by your care team.
What you should do: Keep taking both exactly as prescribed unless told otherwise, and let your pharmacist or doctor know you are on both so they can review your plan.
Management is individual — confirm any change with your pharmacist or prescriber.
Common questions
Can I take Cariprazine and Telotristat Ethyl together?
Telotristat may speed up the enzyme that handles cariprazine, and the combined effect is unpredictable, so this pairing is not recommended without your care team's review. Don't change anything on your own; talk to your pharmacist or doctor. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Cariprazine and Telotristat Ethyl interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Cariprazine and Telotristat Ethyl interaction managed?
Here is how a care team typically handles this pairing: The manufacturer labeling says this combination is not recommended, so your prescriber may consider an alternative or weigh whether both drugs are truly needed together. If you do take both, your team may monitor you more closely for changes in how well cariprazine is working or for new side effects, since the net effect is unpredictable. You… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
Questions for your pharmacist
- Does my dose of Cariprazine or Telotristat Ethyl need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (1)
- Product Information: VRAYLAR(R) oral capsules, cariprazine oral capsules. AbbVie Inc. (per FDA), North Chicago, IL, 2024. DailyMed
Keep reading about Telotristat Ethyl
Keep reading about Cariprazine
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist